Literature DB >> 21537028

In vitro susceptibility of Pythium insidiosum to macrolides and tetracycline antibiotics.

Erico Silva Loreto1, Débora Alves Nunes Mario, Laura Bedin Denardi, Sydney Hartz Alves, Janio Morais Santurio.   

Abstract

We describe the in vitro activity of macrolides and tetracycline antibiotics against Pythium insidiosum. The MICs were determined according to CLSI procedures (visual MIC) and by a colorimetric method [3-(4,5-dimethyl-2-thiazyl)-2,5-diphenyl-2H-tetrazolium bromide (MTT)]. The lowest geometric mean (GM) MIC (MICs in μg/ml) (0.39 and 0.7 by visual reading and colorimetric method, respectively) and MIC ranges (0.125 to 2.0) were obtained for minocycline, while the highest MICs were shown for erythromycin (GM of 7.58 and 12.25 by visual reading and colorimetric method, respectively, and MIC ranged from 2 to 32). This significant in vitro activity makes these classes of antibiotics good candidates for experimental treatment of pythiosis.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21537028      PMCID: PMC3122472          DOI: 10.1128/AAC.01586-10

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  16 in total

1.  In vitro activities of voriconazole, itraconazole, and terbinafine alone or in combination against Pythium insidiosum isolates from Brazil.

Authors:  Juliana S Argenta; Janio M Santurio; Sydney H Alves; Daniela I B Pereira; Ayrton S Cavalheiro; Andréia Spanamberg; Laerte Ferreiro
Journal:  Antimicrob Agents Chemother       Date:  2007-12-03       Impact factor: 5.191

2.  In Vitro activity of terbinafine combined with caspofungin and azoles against Pythium insidiosum.

Authors:  Ayrton S Cavalheiro; Grazieli Maboni; Maria I de Azevedo; Juliana S Argenta; Daniela I B Pereira; Tatiana B Spader; Sydney H Alves; Janio M Santurio
Journal:  Antimicrob Agents Chemother       Date:  2009-03-16       Impact factor: 5.191

3.  In vitro activity of terbinafine associated to amphotericin B, fluvastatin, rifampicin, metronidazole and ibuprofen against Pythium insidiosum.

Authors:  Ayrton S Cavalheiro; Régis A Zanette; Tatiana B Spader; Luciane Lovato; Maria Isabel Azevedo; Sonia Botton; Sydney H Alves; Janio M Santurio
Journal:  Vet Microbiol       Date:  2009-01-31       Impact factor: 3.293

4.  Successful medical therapy for deeply invasive facial infection due to Pythium insidiosum in a child.

Authors:  J L Shenep; B K English; L Kaufman; T A Pearson; J W Thompson; R A Kaufman; G Frisch; M G Rinaldi
Journal:  Clin Infect Dis       Date:  1998-12       Impact factor: 9.079

5.  Potentiation of antifungal activity of amphotericin B by azithromycin against Aspergillus species.

Authors:  M H Nguyen; C J Clancy; Y C Yu; A S Lewin
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-11       Impact factor: 3.267

6.  The combination of minocycline and fluconazole causes synergistic growth inhibition against Candida albicans: an in vitro interaction of antifungal and antibacterial agents.

Authors:  Wenna Shi; Zuozhong Chen; Xu Chen; Lili Cao; Ping Liu; Shujuan Sun
Journal:  FEMS Yeast Res       Date:  2010-08-12       Impact factor: 2.796

Review 7.  Pythium insidiosum: an overview.

Authors:  Wim Gaastra; Len J A Lipman; Arthur W A M De Cock; Tim K Exel; Raymond B G Pegge; Josje Scheurwater; Raquel Vilela; Leonel Mendoza
Journal:  Vet Microbiol       Date:  2010-07-24       Impact factor: 3.293

8.  Antifungal activity of four tetracycline analogues against Candida albicans in vitro: potentiation by amphotericin B.

Authors:  M A Lew; K M Beckett; M J Levin
Journal:  J Infect Dis       Date:  1977-08       Impact factor: 5.226

9.  Caspofungin in vitro and in vivo activity against Brazilian Pythium insidiosum strains isolated from animals.

Authors:  Daniela Isabel Brayer Pereira; Janio Morais Santurio; Sydney Hartz Alves; Juliana Siqueira Argenta; Luciana Pötter; Andréia Spanamberg; Laerte Ferreiro
Journal:  J Antimicrob Chemother       Date:  2007-09-03       Impact factor: 5.790

Review 10.  Human protothecosis.

Authors:  Cornelia Lass-Flörl; Astrid Mayr
Journal:  Clin Microbiol Rev       Date:  2007-04       Impact factor: 26.132

View more
  16 in total

1.  In Vitro Activities of Miltefosine and Antibacterial Agents from the Macrolide, Oxazolidinone, and Pleuromutilin Classes against Pythium insidiosum and Pythium aphanidermatum.

Authors:  Erico S Loreto; Juliana S M Tondolo; Daniele C Oliveira; Janio M Santurio; Sydney H Alves
Journal:  Antimicrob Agents Chemother       Date:  2018-02-23       Impact factor: 5.191

2.  Combat-Related Pythium aphanidermatum Invasive Wound Infection: Case Report and Discussion of Utility of Molecular Diagnostics.

Authors:  Aaron R Farmer; Clinton K Murray; Ian R Driscoll; Brian L Wickes; Nathan Wiederhold; Deanna A Sutton; Carmita Sanders; Katrin Mende; Brent Enniss; James Feig; Anuradha Ganesan; Elizabeth A Rini; Todd J Vento
Journal:  J Clin Microbiol       Date:  2015-04-01       Impact factor: 5.948

3.  The Disulfide Bond of the Peptide Thanatin Is Dispensible for Its Antimicrobial Activity In Vivo and In Vitro.

Authors:  Bo Ma; Chao Niu; Ying Zhou; Xiaoyan Xue; Jingru Meng; Xiaoxing Luo; Zheng Hou
Journal:  Antimicrob Agents Chemother       Date:  2016-06-20       Impact factor: 5.191

4.  In vitro synergism observed with azithromycin, clarithromycin, minocycline, or tigecycline in association with antifungal agents against Pythium insidiosum.

Authors:  Francielli P K Jesus; Laerte Ferreiro; Érico S Loreto; Maiara B Pilotto; Aline Ludwig; Karine Bizzi; Juliana S M Tondolo; Régis A Zanette; Sydney H Alves; Janio M Santurio
Journal:  Antimicrob Agents Chemother       Date:  2014-07-07       Impact factor: 5.191

5.  New insights into the in vitro susceptibility of Pythium insidiosum.

Authors:  Erico S Loreto; Juliana S M Tondolo; Maiara B Pilotto; Sydney H Alves; Janio M Santurio
Journal:  Antimicrob Agents Chemother       Date:  2014-09-15       Impact factor: 5.191

6.  In Vitro Susceptibility of Thai Pythium insidiosum Isolates to Antibacterial Agents.

Authors:  Navaporn Worasilchai; Ariya Chindamporn; Rongpong Plongla; Pattama Torvorapanit; Kasama Manothummetha; Nipat Chuleerarux; Nitipong Permpalung
Journal:  Antimicrob Agents Chemother       Date:  2020-03-24       Impact factor: 5.191

7.  In vitro susceptibility of Pythium insidiosum isolates to aminoglycoside antibiotics and tigecycline.

Authors:  Deise Luiza Mahl; Francielli Pantella Kunz de Jesus; Érico Silva Loreto; Régis Adriel Zanette; Laerte Ferreiro; Maiara Ben Pilotto; Sydney Hartz Alves; Janio Morais Santurio
Journal:  Antimicrob Agents Chemother       Date:  2012-04-16       Impact factor: 5.191

8.  In vitro susceptibility of Brazilian Pythium insidiosum isolates to essential oils of some Lamiaceae family species.

Authors:  A O S Fonseca; D I B Pereira; R G Jacob; F S Maia Filho; D H Oliveira; B P Maroneze; J S S Valente; L G Osório; S A Botton; M C A Meireles
Journal:  Mycopathologia       Date:  2014-11-28       Impact factor: 2.574

9.  R-thanatin inhibits growth and biofilm formation of methicillin-resistant Staphylococcus epidermidis in vivo and in vitro.

Authors:  Zheng Hou; Fei Da; Baohui Liu; Xiaoyan Xue; Xiuli Xu; Ying Zhou; Mingkai Li; Zhi Li; Xue Ma; Jingru Meng; Min Jia; Yukun Wang; Xiaoxing Luo
Journal:  Antimicrob Agents Chemother       Date:  2013-08-05       Impact factor: 5.191

10.  In Vitro and In Vivo Antimicrobial Activities of Minocycline in Combination with Azithromycin, Clarithromycin, or Tigecycline against Pythium insidiosum.

Authors:  Francielli P K Jesus; Érico S Loreto; Laerte Ferreiro; Sydney H Alves; David Driemeier; Suyene O Souza; Raqueli T França; Sonia T A Lopes; Maiara B Pilotto; Aline Ludwig; Maria I Azevedo; Tatiana C Ribeiro; Juliana S M Tondolo; Janio M Santurio
Journal:  Antimicrob Agents Chemother       Date:  2015-10-12       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.